Cargando…

Pancreatic Neuroendocrine Tumors in Glucagon Receptor-Deficient Mice

Inhibition of glucagon signaling causes hyperglucagonemia and pancreatic α cell hyperplasia in mice. We have recently demonstrated that a patient with an inactivating glucagon receptor mutation (P86S) also exhibits hyperglucagonemia and pancreatic α cell hyperplasia but further develops pancreatic n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Run, Dhall, Deepti, Nissen, Nicholas N., Zhou, Cuiqi, Ren, Song-Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154424/ https://www.ncbi.nlm.nih.gov/pubmed/21853126 http://dx.doi.org/10.1371/journal.pone.0023397

Ejemplares similares

Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study
por: Zhu, Li-Ming, et al.
Publicado: (2016)

Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides
por: Takano, Yuko, et al.
Publicado: (2015)

Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment
por: Ro, Cynthia, et al.
Publicado: (2013)

GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass
por: Guimarães, Marta, et al.
Publicado: (2015)

Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
por: Carter, Angela M., et al.
Publicado: (2021)

Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
por: Lee, Young, et al.
Publicado: (2011)

Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice
por: Lafferty, Ryan A, et al.
Publicado: (2022)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

Glucagon-producing cells are increased in Mas-deficient mice
por: Felix Braga, Janaína, et al.
Publicado: (2016)

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
por: Pocai, Alessandro, et al.
Publicado: (2009)

Upregulation of Somatostatin Receptor Type 2 Improves (177)Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model
por: Sharma, Rupali, et al.
Publicado: (2023)

Constitutive Somatostatin Receptor Subtype-3 Signaling Suppresses Growth Hormone Synthesis
por: Eigler, Tamar, et al.
Publicado: (2014)

Diagnosis of Pancreatic Neuroendocrine Tumors
por: Lee, Dong Wook, et al.
Publicado: (2017)

Hypothalamic Glucagon Receptors Regulate Feeding in Mice
por: Cunningham, Stephen E, et al.
Publicado: (2021)

Pancreatic paraganglioma mimicking pancreatic neuroendocrine tumor
por: Abbasi, Arezou, et al.
Publicado: (2020)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
por: Hu, Yuheng, et al.
Publicado: (2021)

Time-trend and recurrence analysis of pancreatic neuroendocrine tumors
por: Kim, Hanbaro, et al.
Publicado: (2019)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
por: Ehehalt, Florian, et al.
Publicado: (2010)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
por: BELOTTO, Marcos, et al.
Publicado: (2019)

Treatment Options for Pancreatic Neuroendocrine Tumors
por: Akirov, Amit, et al.
Publicado: (2019)

Surgical Management of Pancreatic Neuroendocrine Tumors
por: Sulciner, Megan L., et al.
Publicado: (2023)

Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice
por: Wei, Tianjiao, et al.
Publicado: (2023)

Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors()()
por: Miao, Dong-liu, et al.
Publicado: (2018)

Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment
por: Zhang, Ming-Yi, et al.
Publicado: (2020)

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors
por: Simon, Tincy, et al.
Publicado: (2022)

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
por: Starr, Jason S, et al.
Publicado: (2020)

Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors
por: Song, Yu-Li, et al.
Publicado: (2017)

Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in Mice
por: Koehler, Jacqueline A., et al.
Publicado: (2009)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

Intestinal Growth in Glucagon Receptor Knockout Mice Is Not Associated With the Formation of AOM/DSS-Induced Tumors
por: Hunt, Jenna Elizabeth, et al.
Publicado: (2021)

Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis
por: Morvaridi, Susan, et al.
Publicado: (2015)

Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells
por: Fielitz, Kathrin, et al.
Publicado: (2016)

Pancreatic Collision Tumor of Ductal Adenocarcinoma and Neuroendocrine Tumor
por: Wang, Yuchen, et al.
Publicado: (2018)

Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors
por: Chen, Hong-Yu, et al.
Publicado: (2020)

Pancreatic Neuroendocrine Tumor with Atypical Radiologic Presentation
por: Singh, Ramandeep, et al.
Publicado: (2015)

Recent developments in imaging of pancreatic neuroendocrine tumors
por: Kartalis, Nikolaos, et al.
Publicado: (2015)

Irreversible electroporation for the treatment of pancreatic neuroendocrine tumors
por: Papamichail, Michail, et al.
Publicado: (2016)

Metastatic neuroendocrine pancreatic tumor – Case report
por: Radu, EC, et al.
Publicado: (2018)

EUS diagnosis of cystic pancreatic neuroendocrine tumors
por: Li-Geng, Tony, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7esqk7d8ljfb2gbbi1vj1bf92s